Key stats
About SPDR S&P BIOTECH ETF
Home page
Inception date
Jan 31, 2006
Structure
Open-Ended Fund
Replication method
Physical
Dividend treatment
Distributes
Distribution tax treatment
Qualified dividends
Income tax type
Capital Gains
Max ST capital gains rate
39.60%
Max LT capital gains rate
20.00%
Primary advisor
SSgA Funds Management, Inc.
Distributor
State Street Corp. (Fund Distributor)
XBI provides exposure to US biotech stocks, as defined by GICS, from a universe that invests across the market-cap spectrum. The fund equal-weights its portfolio, which in turn emphasizes small- and micro-caps and greatly reduces single-name risk. Thus, the weighted-average market-cap is much smaller than some competitors. Unlike other funds in this segment, XBI is a pure biotech play, with relatively small pharma overlap. The index is rebalanced quarterly.
Classification
Returns
| 1 month | 3 months | Year to date | 1 year | 3 years | 5 years | |
|---|---|---|---|---|---|---|
| Price performance | — | — | — | — | — | — |
| NAV total return | — | — | — | — | — | — |
What's in the fund
Exposure type
Health Technology
Stocks99.83%
Health Technology99.83%
Bonds, Cash & Other0.17%
Mutual fund0.12%
Miscellaneous0.04%
Stock breakdown by region
North America95.88%
Europe4.12%
Latin America0.00%
Asia0.00%
Africa0.00%
Middle East0.00%
Oceania0.00%
Top 10 holdings
Dividends
Dividend payout history
Assets under management (AUM)
Fund Flows
Frequently Asked Questions
SSGF top holdings are Insmed Incorporated and Alnylam Pharmaceuticals, Inc, occupying 3.25% and 3.13% of the portfolio correspondingly.
SSGF last dividends amounted to 0.00 EUR. The quarter before, the issuer paid 0.00 EUR in dividends, which shows a 46.87% increase.
Yes, SSGF pays dividends to its holders with the dividend yield of 0.17%. The last dividend (Mar 26, 2025) amounted to 0.00 EUR. The dividends are paid quarterly.
SSGF shares are issued by State Street Corp. under the brand SPDR. The ETF was launched on Jan 31, 2006, and its management style is Passive.
SSGF expense ratio is 0.35% meaning you'd have to pay 0.35% of your investment to help manage the fund.
SSGF follows the S&P Biotechnology Select Industry. ETFs usually track some benchmark seeking to replicate its performance and guide asset selection and objectives.
SSGF invests in stocks.